Clinical Trial Update: A Study of Different Formulations of the L-PPDS in Subjects With OH or OAG [Phase 2]

View source ↗

Summary

A completed Phase 2 clinical trial evaluating different formulations of L-PPDS in subjects with glaucoma or ocular hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• L-PPDS

Snippet

Sponsor: Mati Therapeutics Inc. | Conditions: Glaucoma, Ocular Hypertension | Phase 2 | Status: COMPLETED